<DOC>
	<DOCNO>NCT00599664</DOCNO>
	<brief_summary>Evaluate safety systemic absorption OMS201 follow exposure ureteroscopy .</brief_summary>
	<brief_title>Pharmacokinetic Safety Study OMS201 Subjects Undergoing Ureteroscopic Treatment Removal Urinary Tract-Located Stones</brief_title>
	<detailed_description>OMS201 develop facilitate endoscopy ureter reduce postoperative discomfort , pain , frequency , urgency and/or difficult urination follow endoscopic surgery remove urinary tract stone .</detailed_description>
	<mesh_term>Calculi</mesh_term>
	<mesh_term>Urinary Calculi</mesh_term>
	<mesh_term>Urolithiasis</mesh_term>
	<criteria>Subject undergoing unilateral ureteroscopic removal renal collecting system ureteral stone locate ureter maximum stone diameter 12 mm , general anesthesia use . Subject 's physical examination within normal limit examination clinically nonsignificant purpose study determine Investigator , subject good general health . Subject 's laboratory evaluation within normal limit evaluation clinically nonsignificant determine Investigator . Female subject childbearing potential use effective method birth control within least 14 day prior surgery negative pregnancy test . Subject minimal risk anesthesia classify accord American Society Anesthesiologists Physical Status Classification either PS1 PS2 . Subject 's body mass index 19 35 , inclusive , base Body Mass Index Table . Subject take prohibited medication . Subject renal transplant , single kidney evidence compromise renal function measure abnormal serum creatinine , judge Investigator , evidence urinary tract infection , prior history open laparoscopic surgery , history ureteral stricture . Subject congenital anomaly would engender increased procedural safety risk ureteropelvic junction obstruction result severely dilate renal pelvis , duplicate urinary collecting system , horseshoe kidney vascular anomaly renal arteriovenous fistula papillary necrosis . Subject bilateral renal ureteral stone require concurrent ureteroscopic removal . Subject clinically significant hypotension Screening . Subject present condition history clinically significant uncontrolled gastrointestinal , cardiovascular , hepatic , renal , hematological , endocrine , neurological , psychiatric , connective tissue , respiratory medical disorder determine Investigator . Subject chronic diuretic use . Subject take used investigational drug device within 30 day prior day surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Urinary Calculi</keyword>
	<keyword>Urinary Stones</keyword>
	<keyword>Urinary Tract Stones</keyword>
	<keyword>Calculi</keyword>
</DOC>